In a major scientific advance, Progenra Inc. has announced the discovery of a novel class of small-molecule drugs designed to restore the function of mutant forms of ...

This article reviews the PINK1 protein product, which has been implicated in several functions, mostly aimed at protecting neuronal cells against different types of stress.

Discover how scientists imaged the Parkinson’s protein PINK1, unlocking insight into its role in mitochondrial quality control and brain cell survival.

University of Dundee scientists have discovered a new target that could herald the development of new drugs to treat Parkinson’s disease.

Study reveals the structure of PINK1 protein, offering fresh hope for Parkinson's patients through potential targeted therapies that address root causes.

Researchers at the WEHI Parkinson’s Disease Research Centre have determined the first ever structure of human PINK1 bound to mitochondria, in findings published in Science.

PINK1 protein discovery could accelerate Parkinsons disease drug development New insights into mitochondria may pave the way for innovative treatments in neurodegenerative disorders.

Scientists have made a potentially “life-changing” discovery that could pave the way for new drugs to treat Parkinson’s disease.

A form of Parkinson’s disease caused by mutations in a gene known as PINK1 has long been labelled rare. But our research shows it’s anything but – at least for some populations. Our meta-analysis ...

Strengths: (1) The study addresses an important topic in neuroscience, exploring the mechanisms of Pink1 loss, which has implications for Parkinson's disease and neurodegeneration. (2) The focus on ...